Maintenance of Myocardial Levels of Vitamin A in Heart Failure due to Adriamycin
- 1 July 2002
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 34 (7) , 789-795
- https://doi.org/10.1006/jmcc.2002.2015
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Needs and Sources of Carotenoids and Vitamin ANutrition Reviews, 2009
- Doxorubicin-Induced CardiomyopathyNew England Journal of Medicine, 1998
- Adriamycin cardiomyopathy: pathophysiology and preventionThe FASEB Journal, 1997
- Cardiac Failure and Dysrhythmias 6–19 Years After Anthracycline Therapy: A Series of 15 PatientsMedical and Pediatric Oncology, 1995
- Combination therapy with probucol prevents adriamycin-induced cardiomyopathyJournal of Molecular and Cellular Cardiology, 1995
- Probucol Protects Against Adriamycin Cardiomyopathy Without Interfering With Its Antitumor EffectCirculation, 1995
- Antioxidant Activity of All-trans-retinol in Homogeneous Solution and in Phosphatidylcholine LiposomesArchives of Biochemistry and Biophysics, 1993
- Cardiac ultrastructural changes induced by daunorubicin therapyCancer, 1973
- A clinicopathologic analysis of adriamycin cardiotoxicityCancer, 1973
- THE EFFECTS OF CAROTENE AND OF VITAMIN A ON THE OXIDATION OF LINOLEIC ACIDJournal of Biological Chemistry, 1932